64.60
-4.99
(-7.17%)
At close: April 16 at 4:00:01 PM EDT
64.75
+0.15
+(0.23%)
Pre-Market: 8:54:39 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | Sale | Apr 1, 2025 | -- |
| GUYER WILLIAM Officer | Sale | Apr 1, 2025 | 5,487 |
| HUNT HAZEL Officer | Conversion of Exercise of derivative security | Feb 11, 2025 | 183,405 |
| LYON JOSEPH DOUGLAS Chief Technology Officer | Sale | Apr 1, 2025 | 9,009 |
| MADUCK SEAN Officer | Sale | Apr 1, 2025 | 105,622 |
| MAHONEY DAVID L Director | Conversion of Exercise of derivative security | Apr 10, 2024 | 1,286,570 |
| MOKARI ATABAK Chief Financial Officer | Stock Award(Grant) | Mar 3, 2025 | 13,034 |
| ROBB GARY CHARLES Officer | Stock Gift | Mar 12, 2025 | 29,530 |
| SWISHER DANIEL N JR Director | Sale | Apr 10, 2025 | -- |
| WILSON JAMES N Director | Stock Gift | Jan 27, 2025 | -- |
Related Tickers
CYTK Cytokinetics, Incorporated
39.15
+1.53%
SLNO Soleno Therapeutics, Inc.
69.93
-0.46%
PTGX Protagonist Therapeutics, Inc.
45.80
-2.45%
ADMA ADMA Biologics, Inc.
21.23
-4.15%
VRNA Verona Pharma plc
58.30
-0.29%
TGTX TG Therapeutics, Inc.
38.21
-2.10%
CPRX Catalyst Pharmaceuticals, Inc.
22.19
-4.48%
PCVX Vaxcyte, Inc.
29.12
-3.67%
HALO Halozyme Therapeutics, Inc.
58.82
-4.01%
EXEL Exelixis, Inc.
36.15
-1.07%